
Michelle Dietzen
@michi_dii
cancer research | cancer evolution | immunotherapy | cancer vaccines | bioinformatics
ID: 994879395692253184
11-05-2018 09:58:26
19 Tweet
140 Followers
180 Following



Years of work on genome doubling (WGD) in cancer TRACERx Nicholas McGranahan and UCL Cancer Institute The Francis Crick Institute : how WGD mitigates chromosomal instability driven loss of lung cancer essential genes - and overcomes “mutational meltdown” nature.com/articles/s4158…


Our paper, a collaboration with Enkhtsetseg Munkhbaatar, Philipp Jost and Nicholas McGranahan is published in Nature Communications! We highlight the frequent occurrence of MCL-1 gains in lung adenocarcinoma and explore the potential of MCL-1 as a therapeutic target. nature.com/articles/s4146…

You always had trouble understanding tumour evolution? Our new SnapShot in Cell highlights the key concepts of tumour evolution and drivers of diversity for you. Thanks for the great collaboration Ariana Huebner and Nicholas McGranahan! cell.com/cell/fulltext/…

Excited to share our Cell SnapShot on Tumor Evolution which sheds light on key concepts of tumor evolution and drivers of diversity. Plus it looks great as a poster! Michelle Dietzen Nicholas McGranahan cell.com/cell/fulltext/…

Amazing to see Nicholas McGranahan and his work inferring T cell infiltrate in tumours from NGS data - started in my lab 2013 as PhD student then independent PI 2018 UCL Cancer Institute CRUK Lung Centre a talented scientist I now learn from! nature.com/articles/s4158…


I'm fundraising for Tommy's, the baby charity. Check out my JustGiving page and please donate if you can. Thank you! #JustGiving justgiving.com/fundraising/mi…



[POSTDOC]We're seeking a Science and Innovation at Cancer Research UK compbio postdoc to develop algorithms and evolutionary models to investigate metastasis with single-cell whole-genome seq at UCL Cancer Institute working on #TRACERx with CRUK Lung Centre Charles Swanton @MariamJHanjani Nicholas McGranahan and many others

Today at #AACR22, look out for Michelle Dietzen showcasing SignaTree, a tool to identify evolutionary trajectories of the activity of mutational processes in tumour development. Join at 19:30 BST: abstractsonline.com/pp8/#!/10517/p… #CRUKFunded UCL Cancer Institute

Certainly am! If you're around come and see what we (@CarlosEcolEvol and I with Nicholas McGranahan Charles Swanton and many others) have found looking into transcriptomic diversity in #TRACERx multi-region NSCLC. Section 10 Board 18 from 1.30pm. #AACR22 Cancer Research UK UCL Cancer Institute

Great catching up with you Michelle Dietzen and congratulations on your great work. Nicholas McGranahan #AACR2022


Fantastic talk by Michelle Dietzen on altered replication timing in cancer…and lots of interesting discussion #AACR22 #proudPI #cancerevolution


We're thrilled to share work on tumour evolution in 421 TRACERx lung cancer patients by Alex Frankell Michelle Dietzen Maise Al Bakir Emilia Lim Takahiro Karasaki Sophie Ward RajuVeeriah Emma Colliver Ariana Huebner Abi Bunkum Simone Zaccaria @MariamJHanjani Nicholas McGranahan🧵⬇️ nature.com/articles/s4158…

My main PhD project is finally out 🎉 it was such an honour to investigate replication timing with Haoran Zhai 🥳 many thanks for all the great support to Nicholas McGranahan Nnennaya Kanu and Charles Swanton and all the great scientists that helped us along the way 🫶🏽